New microRNA Biomarkers for Drug-Induced Steatosis and Their Potential to Predict the Contribution of Drugs to Non-alcoholic Fatty Liver Disease

Background and Aims: Drug-induced steatosis is a major reason for drug failure in clinical trials and post-marketing withdrawal; and therefore, predictive biomarkers are essential. These could be particularly relevant in non-alcoholic fatty liver disease (NAFLD), where most patients show features of...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Riera, Mireia, Conde, Isabel, Tolosa, Laia, Zaragoza, Ángela, Castell, José V., Gómez-Lechón, María J., Jover, Ramiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5263149/
https://www.ncbi.nlm.nih.gov/pubmed/28179883
http://dx.doi.org/10.3389/fphar.2017.00003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5263149/
https://www.ncbi.nlm.nih.gov/pubmed/28179883
http://dx.doi.org/10.3389/fphar.2017.00003

Ejemplares similares